These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16148552)

  • 41. Post-infectious irritable bowel syndrome following water contamination.
    Marshall JK
    Kidney Int Suppl; 2009 Feb; (112):S42-3. PubMed ID: 19180133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Postinfectious irritable bowel syndrome].
    Döbrönte Z; Lakner L; Sarang K
    Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis.
    Porter CK; Welsh M; Riddle MS; Nieh C; Boyko EJ; Gackstetter G; Hooper TI
    Aliment Pharmacol Ther; 2017 Apr; 45(8):1115-1127. PubMed ID: 28230274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective study evaluating immune-mediated mechanisms and predisposing factors underlying persistent postinfectious abdominal complaints.
    Florens MV; Van Wanrooy S; Dooley J; Aguilera-Lizarraga J; Vanbrabant W; Wouters MM; Van Oudenhove L; Peetermans WE; Liston A; Boeckxstaens GE
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13542. PubMed ID: 30657233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: A multicenter study.
    Yao X; Yang YS; Cui LH; Sun G; Peng LH; Wang WF; Hyder Q; Zhang XL
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1584-93. PubMed ID: 26875585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postinfectious functional gastrointestinal disorders.
    Mearin F
    J Clin Gastroenterol; 2011 Aug; 45 Suppl():S102-5. PubMed ID: 21666422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and risk factors of irritable bowel syndrome in community subjects with culture-proven bacterial gastroenteritis.
    Koh SJ; Lee DH; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Kim N; Im JP; Kim JS; Jung HC
    Korean J Gastroenterol; 2012 Jul; 60(1):13-8. PubMed ID: 22832795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.
    Klem F; Wadhwa A; Prokop LJ; Sundt WJ; Farrugia G; Camilleri M; Singh S; Grover M
    Gastroenterology; 2017 Apr; 152(5):1042-1054.e1. PubMed ID: 28069350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional gastrointestinal disorders in eating disorder patients: altered distribution and predictors using ROME III compared to ROME II criteria.
    Wang X; Luscombe GM; Boyd C; Kellow J; Abraham S
    World J Gastroenterol; 2014 Nov; 20(43):16293-9. PubMed ID: 25473186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-infectious irritable bowel syndrome.
    Thabane M; Marshall JK
    World J Gastroenterol; 2009 Aug; 15(29):3591-6. PubMed ID: 19653335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Post-infectious IBS].
    Kamikozuru K; Matsumoto T; Miwa H
    Nihon Rinsho; 2006 Aug; 64(8):1544-8. PubMed ID: 16898630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-infectious irritable bowel syndrome.
    Rhodes DY; Wallace M
    Curr Gastroenterol Rep; 2006 Aug; 8(4):327-32. PubMed ID: 16836945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histopathological alterations in post-infectious irritable bowel syndrome in Bangladeshi population.
    Bhuiyan MR; Majumder TK; Raihan AA; Roy PK; Farha N; Kamal M
    Mymensingh Med J; 2010 Apr; 19(2):275-81. PubMed ID: 20395926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis.
    Spence MJ; Moss-Morris R
    Gut; 2007 Aug; 56(8):1066-71. PubMed ID: 17324974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
    J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R; Savarese MF; Gargano R
    Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
    Ruigómez A; García Rodríguez LA; Panés J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-infectious irritable bowel syndrome in patients with Shigella infection.
    Ji S; Park H; Lee D; Song YK; Choi JP; Lee SI
    J Gastroenterol Hepatol; 2005 Mar; 20(3):381-6. PubMed ID: 15740480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.